Next generation genome editing
Next generation genome editing for Recessive Dystrophic Epidermolysis Bullosa...
Next generation genome editing for Recessive Dystrophic Epidermolysis Bullosa...
Stem cell regeneration of the ocular surface in Recessive Dystrophic Epidermolysis Bullosa...
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text] Limbal stem cells for treatment of corneal wounds in Epidermolysis Bullosa Investigator(s)Prof Jakub Tolar, University of MinnesotaFundingUS $250,000 (£165,000) Cure EB (formerly the Sohana Research Fund under DEBRA UK)Start dateJanuary 2014End dateAugust 2015Research areaGene editing, Cell therapyAimQuality of life...
A TALEN-based approach to developing safer, more effective treatments for people with Epidermolysis Bullosa...